Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	lysine-acetylated histone binding	MLLT1 BRD2 BRDT BRD4	1.64e-07	30	33	4	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	MLLT1 BRD2 BRDT BRD4	1.88e-07	31	33	4	GO:0140033
GeneOntologyMolecularFunction	histone binding	NAP1L3 MLLT1 CHD8 BRD2 BRDT BRD4 CBX2	2.13e-07	265	33	7	GO:0042393
GeneOntologyMolecularFunction	modification-dependent protein binding	MLLT1 CHD8 BRD2 BRDT BRD4 CBX2	9.84e-07	206	33	6	GO:0140030
GeneOntologyMolecularFunction	P-TEFb complex binding	JMJD6 BRD4	1.59e-05	4	33	2	GO:0106140
GeneOntologyMolecularFunction	RNA polymerase core enzyme binding	RTF1 BRD4 RPAP2	5.57e-05	45	33	3	GO:0043175
GeneOntologyMolecularFunction	RNA polymerase II C-terminal domain binding	RTF1 BRD4	1.44e-04	11	33	2	GO:0099122
GeneOntologyMolecularFunction	RNA polymerase binding	RTF1 BRD4 RPAP2	1.68e-04	65	33	3	GO:0070063
GeneOntologyMolecularFunction	RNA polymerase II CTD heptapeptide repeat modifying activity	BRD4 RPAP2	6.56e-04	23	33	2	GO:0140994
GeneOntologyMolecularFunction	cyclosporin A binding	PPIG NKTR	7.15e-04	24	33	2	GO:0016018
GeneOntologyMolecularFunction	histone reader activity	BRDT BRD4	8.40e-04	26	33	2	GO:0140566
GeneOntologyMolecularFunction	beta-catenin binding	SETD1A CHD8 KANK1	1.01e-03	120	33	3	GO:0008013
GeneOntologyMolecularFunction	chromatin binding	NAP1L3 MLLT1 CHD8 BRD2 BRD4 CBX2	1.19e-03	739	33	6	GO:0003682
GeneOntologyMolecularFunction	histone demethylase activity	FBXL19 JMJD6	1.20e-03	31	33	2	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	FBXL19 JMJD6	1.27e-03	32	33	2	GO:0140457
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	CHD9 CHD8	1.70e-03	37	33	2	GO:0140658
GeneOntologyMolecularFunction	RNA polymerase II complex binding	RTF1 BRD4	1.89e-03	39	33	2	GO:0000993
GeneOntologyMolecularFunction	chromatin-protein adaptor activity	BRDT BRD4	2.09e-03	41	33	2	GO:0140463
GeneOntologyMolecularFunction	demethylase activity	FBXL19 JMJD6	2.40e-03	44	33	2	GO:0032451
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	PPIG NKTR	3.09e-03	50	33	2	GO:0003755
GeneOntologyMolecularFunction	cis-trans isomerase activity	PPIG NKTR	3.46e-03	53	33	2	GO:0016859
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	RTF1 BRD4	5.32e-03	66	33	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	RTF1 BRD4	5.32e-03	66	33	2	GO:0001098
GeneOntologyMolecularFunction	histone modifying activity	SETD1A FBXL19 JMJD6	6.30e-03	229	33	3	GO:0140993
GeneOntologyMolecularFunction	p53 binding	CHD8 BRD4	7.17e-03	77	33	2	GO:0002039
GeneOntologyMolecularFunction	methylated histone binding	CHD8 CBX2	8.88e-03	86	33	2	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	CHD8 CBX2	9.28e-03	88	33	2	GO:0140034
GeneOntologyMolecularFunction	transcription coregulator activity	FBXL19 BRDT SPEN BRD4	1.33e-02	562	33	4	GO:0003712
GeneOntologyBiologicalProcess	chromatin organization	RTF1 NAP1L3 SETD1A CHD9 CHD8 FBXL19 BRD2 BRDT JMJD6 BAZ2B BRD4 CBX2	6.40e-09	896	33	12	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	RTF1 NAP1L3 SETD1A CHD9 CHD8 FBXL19 BRD2 BRDT JMJD6 BAZ2B BRD4 CBX2	2.15e-08	999	33	12	GO:0071824
GeneOntologyBiologicalProcess	chromatin remodeling	NAP1L3 SETD1A CHD9 CHD8 FBXL19 BRD2 BRDT JMJD6 BAZ2B BRD4	1.47e-07	741	33	10	GO:0006338
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 cell lineage commitment	BRD2 BRD4	6.91e-05	8	33	2	GO:2000330
GeneOntologyBiologicalProcess	regulation of T-helper 17 cell lineage commitment	BRD2 BRD4	1.35e-04	11	33	2	GO:2000328
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 cell differentiation	BRD2 BRD4	2.23e-04	14	33	2	GO:2000321
GeneOntologyBiologicalProcess	positive regulation of cell fate commitment	BRD2 BRD4	3.74e-04	18	33	2	GO:0010455
GeneOntologyCellularComponent	transcription elongation factor complex	RTF1 MLLT1 AFF1 BRD4 AFF4 AFF3	2.94e-10	56	33	6	GO:0008023
GeneOntologyCellularComponent	super elongation complex	AFF1 AFF4 AFF3	7.15e-08	6	33	3	GO:0032783
GeneOntologyCellularComponent	nuclear protein-containing complex	RTF1 MLLT1 AFF1 SETD1A CHD8 CWC22 BRD4 AFF4 AFF3 CBX2	3.40e-05	1377	33	10	GO:0140513
GeneOntologyCellularComponent	chromatin	NAP1L3 SOX4 SETD1A CHD8 BRD2 BRDT BAZ2B BRD4 AFF4 CBX2	6.29e-05	1480	33	10	GO:0000785
GeneOntologyCellularComponent	euchromatin	SETD1A AFF4 CBX2	1.98e-04	72	33	3	GO:0000791
GeneOntologyCellularComponent	transferase complex	RTF1 SETD1A CHD8 FBXL19 DCAF5 BRD4 CBX2	6.43e-04	963	33	7	GO:1990234
GeneOntologyCellularComponent	nuclear body	SETD1A PPIG BRD2 CWC22 RNF111 AFF3	2.60e-03	903	33	6	GO:0016604
GeneOntologyCellularComponent	nuclear speck	SETD1A PPIG BRD2 CWC22	4.54e-03	431	33	4	GO:0016607
GeneOntologyCellularComponent	histone methyltransferase complex	SETD1A CHD8	6.24e-03	75	33	2	GO:0035097
Domain	TF_AF4/FMR2	AFF1 AFF4 AFF3	1.83e-08	4	32	3	IPR007797
Domain	BET	BRD2 BRDT BRD4	1.83e-08	4	32	3	PF17035
Domain	NET_dom	BRD2 BRDT BRD4	1.83e-08	4	32	3	IPR027353
Domain	NET	BRD2 BRDT BRD4	1.83e-08	4	32	3	PS51525
Domain	AF-4	AFF1 AFF4 AFF3	1.83e-08	4	32	3	PF05110
Domain	Bromodomain_CS	BRD2 BRDT BAZ2B BRD4	1.03e-07	26	32	4	IPR018359
Domain	BROMODOMAIN_1	BRD2 BRDT BAZ2B BRD4	4.50e-07	37	32	4	PS00633
Domain	Bromodomain	BRD2 BRDT BAZ2B BRD4	5.03e-07	38	32	4	PF00439
Domain	BROMODOMAIN_2	BRD2 BRDT BAZ2B BRD4	6.87e-07	41	32	4	PS50014
Domain	BROMO	BRD2 BRDT BAZ2B BRD4	7.59e-07	42	32	4	SM00297
Domain	Bromodomain	BRD2 BRDT BAZ2B BRD4	7.59e-07	42	32	4	IPR001487
Domain	-	BRD2 BRDT BAZ2B BRD4	7.59e-07	42	32	4	1.20.920.10
Domain	BRD4_CDT	BRDT BRD4	2.84e-06	2	32	2	PF17105
Domain	BRD4_CDT	BRDT BRD4	2.84e-06	2	32	2	IPR031354
Domain	Chromo_domain	CHD9 CHD8 CBX2	9.02e-06	24	32	3	IPR023780
Domain	Chromo	CHD9 CHD8 CBX2	1.16e-05	26	32	3	PF00385
Domain	CHROMO_2	CHD9 CHD8 CBX2	1.45e-05	28	32	3	PS50013
Domain	CHROMO_1	CHD9 CHD8 CBX2	1.45e-05	28	32	3	PS00598
Domain	Chromodomain-like	CHD9 CHD8 CBX2	2.19e-05	32	32	3	IPR016197
Domain	CHROMO	CHD9 CHD8 CBX2	2.41e-05	33	32	3	SM00298
Domain	Chromo/shadow_dom	CHD9 CHD8 CBX2	2.41e-05	33	32	3	IPR000953
Domain	BRK	CHD9 CHD8	4.25e-05	6	32	2	SM00592
Domain	BRK_domain	CHD9 CHD8	4.25e-05	6	32	2	IPR006576
Domain	BRK	CHD9 CHD8	4.25e-05	6	32	2	PF07533
Domain	Cyclophilin-type_PPIase_CS	PPIG NKTR	4.78e-04	19	32	2	IPR020892
Domain	Cyclophilin-type_PPIase	PPIG NKTR	5.85e-04	21	32	2	IPR024936
Domain	Pro_isomerase	PPIG NKTR	6.43e-04	22	32	2	PF00160
Domain	-	PPIG NKTR	6.43e-04	22	32	2	2.40.100.10
Domain	Cyclophilin-type_PPIase_dom	PPIG NKTR	6.43e-04	22	32	2	IPR002130
Domain	Cyclophilin-like_dom	PPIG NKTR	6.43e-04	22	32	2	IPR029000
Domain	CSA_PPIASE_1	PPIG NKTR	6.43e-04	22	32	2	PS00170
Domain	CSA_PPIASE_2	PPIG NKTR	6.43e-04	22	32	2	PS50072
Domain	SNF2_N	CHD9 CHD8	1.37e-03	32	32	2	PF00176
Domain	SNF2_N	CHD9 CHD8	1.37e-03	32	32	2	IPR000330
Domain	Znf_FYVE_PHD	FBXL19 RPH3AL BAZ2B	2.00e-03	147	32	3	IPR011011
Domain	HMG_box	SOX4 MEIOSIN	3.71e-03	53	32	2	PF00505
Domain	HMG_BOX_2	SOX4 MEIOSIN	3.85e-03	54	32	2	PS50118
Domain	HMG	SOX4 MEIOSIN	3.85e-03	54	32	2	SM00398
Domain	-	SOX4 MEIOSIN	3.99e-03	55	32	2	1.10.30.10
Domain	HMG_box_dom	SOX4 MEIOSIN	5.53e-03	65	32	2	IPR009071
Domain	-	FBXL19 RPH3AL BAZ2B RNF111	6.96e-03	449	32	4	3.30.40.10
Domain	Znf_RING/FYVE/PHD	FBXL19 RPH3AL BAZ2B RNF111	7.51e-03	459	32	4	IPR013083
Domain	Znf_PHD-finger	FBXL19 BAZ2B	8.07e-03	79	32	2	IPR019787
Domain	PHD	FBXL19 BAZ2B	1.01e-02	89	32	2	SM00249
Domain	Znf_PHD	FBXL19 BAZ2B	1.06e-02	91	32	2	IPR001965
Domain	ZF_PHD_2	FBXL19 BAZ2B	1.15e-02	95	32	2	PS50016
Domain	ZF_PHD_1	FBXL19 BAZ2B	1.17e-02	96	32	2	PS01359
Domain	Helicase_C	CHD9 CHD8	1.44e-02	107	32	2	PF00271
Pathway	REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX	RTF1 MLLT1 AFF4	1.26e-04	58	24	3	M805
Pathway	REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS	RTF1 MLLT1 AFF4	3.39e-04	81	24	3	M865
Pathway	KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION	MLLT1 AFF1	8.81e-04	26	24	2	M47439
Pubmed	AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.	MLLT1 AFF1 BRD4 AFF4	2.21e-10	11	33	4	24367103
Pubmed	MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.	MLLT1 AFF1 AFF4 AFF3	6.68e-10	14	33	4	20854876
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	MLLT1 CHD9 BRD2 BAZ2B BRD4 AFF4 AFF3	1.46e-09	222	33	7	37071664
Pubmed	Lost in transcription: molecular mechanisms that control HIV latency.	MLLT1 AFF1 BRD4 AFF4	2.58e-09	19	33	4	23518577
Pubmed	Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.	AFF1 AFF4 AFF3	3.11e-09	4	33	3	11923441
Pubmed	Expression of BET genes in testis of men with different spermatogenic impairments.	BRD2 BRDT BRD4	3.11e-09	4	33	3	22035730
Pubmed	A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency.	AFF1 BRD4 AFF4	3.11e-09	4	33	3	26830226
Pubmed	Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.	MLLT1 AFF1 AFF4	3.11e-09	4	33	3	25282333
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MLLT1 CHD9 CHD8 BRD2 BRDT JMJD6 DCAF5 BRD4 AFF4 NAF1 RPAP2	3.58e-09	1116	33	11	31753913
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	PPIG KANK1 CWC22 DCAF5 AFF4 NAF1	7.41e-09	156	33	6	22952844
Pubmed	The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.	MLLT1 AFF1 AFF4	2.72e-08	7	33	3	15856011
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	CHD9 CHD8 BRD2 BRDT CWC22 JMJD6 BRD4 NAF1	2.86e-08	533	33	8	30554943
Pubmed	Characterization of the DOT1L network: implications of diverse roles for DOT1L.	MLLT1 AFF1 AFF4 AFF3	6.63e-08	41	33	4	20431927
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	CHD9 CHD8 BRD2 SPEN BAZ2B BRD4 AFF4 CBX2	7.87e-08	608	33	8	36089195
Pubmed	A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.	MLLT1 AFF1 AFF4	9.30e-08	10	33	3	20153263
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SETD1A CHD8 PPIG BRD2 SPEN CWC22	1.25e-07	251	33	6	31076518
Pubmed	HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.	MLLT1 AFF1 AFF4	1.28e-07	11	33	3	20471949
Pubmed	The little elongation complex regulates small nuclear RNA transcription.	MLLT1 AFF1 AFF4	1.70e-07	12	33	3	22195968
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MLLT1 CHD8 BRD2 SPEN CWC22 BAZ2B BRD4 AFF4 CBX2	1.81e-07	954	33	9	36373674
Pubmed	Transcriptional and posttranscriptional regulation of HIV-1 gene expression.	MLLT1 AFF1 AFF4	2.21e-07	13	33	3	22355797
Pubmed	Transcriptional elongation factor ENL phosphorylated by ATM recruits polycomb and switches off transcription for DSB repair.	MLLT1 AFF1 AFF4	2.81e-07	14	33	3	25921070
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SOX4 MLLT1 SETD1A CHD8 FBXL19 BRD2 SPEN BRD4 CBX2	6.19e-07	1105	33	9	35748872
Pubmed	The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.	MLLT1 AFF1 BRD4	6.29e-07	18	33	3	21030982
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX4 FBXL19 BRD2 BRDT PRICKLE3 JMJD6 BRD4 CBX2	6.81e-07	808	33	8	20412781
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BRD2 BRDT BAZ2B BRD4	7.78e-07	75	33	4	25593309
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	RTF1 CHD9 BRD2 SPEN JMJD6	8.04e-07	183	33	5	36129980
Pubmed	Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification.	BRD2 BRD4	8.73e-07	2	33	2	28588073
Pubmed	BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.	BRD2 BRD4	8.73e-07	2	33	2	23115324
Pubmed	Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription.	AFF1 AFF4	8.73e-07	2	33	2	26007649
Pubmed	Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes.	BRD2 BRD4	8.73e-07	2	33	2	26324948
Pubmed	Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation.	BRD2 BRD4	8.73e-07	2	33	2	32151278
Pubmed	Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.	MLLT1 BRD4	8.73e-07	2	33	2	21964340
Pubmed	Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.	BRDT BRD4	8.73e-07	2	33	2	33637650
Pubmed	BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.	BRD2 BRD4	8.73e-07	2	33	2	23255218
Pubmed	Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.	BRD2 BRD4	8.73e-07	2	33	2	16940503
Pubmed	A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.	BRD2 BRD4	8.73e-07	2	33	2	24146614
Pubmed	WHAT do viruses BET on?	BRD2 BRD4	8.73e-07	2	33	2	20036832
Pubmed	Distinct roles of two SEC scaffold proteins, AFF1 and AFF4, in regulating RNA polymerase II transcription elongation.	AFF1 AFF4	8.73e-07	2	33	2	37528066
Pubmed	SARS-CoV-2 E protein interacts with BRD2 and BRD4 SEED domains and alters transcription in a different way than BET inhibition.	BRD2 BRD4	8.73e-07	2	33	2	39066826
Pubmed	AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter.	AFF1 AFF4	8.73e-07	2	33	2	24843025
Pubmed	Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2.	BRD2 BRD4	8.73e-07	2	33	2	35839775
Pubmed	Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population.	AFF1 AFF3	8.73e-07	2	33	2	22983539
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	SOX4 SETD1A CHD8 BRD2 SPEN	1.10e-06	195	33	5	19454010
Pubmed	Infertility with defective spermiogenesis in mice lacking AF5q31, the target of chromosomal translocation in human infant leukemia.	AFF1 AFF4 AFF3	1.18e-06	22	33	3	16024815
Pubmed	The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency.	MLLT1 AFF1 AFF4	1.18e-06	22	33	3	22567366
Pubmed	New insights into the control of HIV-1 transcription: when Tat meets the 7SK snRNP and super elongation complex (SEC).	MLLT1 BRD4 AFF4	1.36e-06	23	33	3	21360054
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	RTF1 MLLT1 AFF1 NKTR BRD2 AFF4 RNF111 AFF3	1.66e-06	910	33	8	36736316
Pubmed	JMJD6-BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells.	JMJD6 BRD4	2.62e-06	3	33	2	37880710
Pubmed	Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability.	AFF4 AFF3	2.62e-06	3	33	2	21330300
Pubmed	Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.	BRD2 BRDT	2.62e-06	3	33	2	28945351
Pubmed	Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.	BRD2 BRD4	2.62e-06	3	33	2	25049379
Pubmed	Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited.	MLLT1 AFF1	2.62e-06	3	33	2	16433901
Pubmed	Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.	BRD2 BRD4	2.62e-06	3	33	2	24049186
Pubmed	AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).	AFF1 AFF4	2.62e-06	3	33	2	10588740
Pubmed	Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system.	BRD2 BRD4	2.62e-06	3	33	2	31792058
Pubmed	NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells.	BRD2 BRD4	2.62e-06	3	33	2	30300821
Pubmed	Characterization of BRD4 during mammalian postmeiotic sperm development.	BRDT BRD4	2.62e-06	3	33	2	25691659
Pubmed	BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition.	BRD2 BRD4	2.62e-06	3	33	2	29437854
Pubmed	Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.	BRD2 BRD4	2.62e-06	3	33	2	28262505
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	BRD2 SPEN CWC22 BRD4	2.78e-06	103	33	4	32744500
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	MLLT1 AFF1 BRD2 AFF4 RNF111 AFF3	2.96e-06	432	33	6	23455922
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	CHD9 CHD8 SPEN CBX2	3.48e-06	109	33	4	33554859
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETD1A CHD8 BRD2 ZCCHC10 SPEN BRD4	4.74e-06	469	33	6	27634302
Pubmed	LYAR potentiates rRNA synthesis by recruiting BRD2/4 and the MYST-type acetyltransferase KAT7 to rDNA.	BRD2 BRD4	5.23e-06	4	33	2	31504794
Pubmed	Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4.	JMJD6 BRD4	5.23e-06	4	33	2	29176719
Pubmed	Mediation of Af4 protein function in the cerebellum by Siah proteins.	AFF1 AFF4	5.23e-06	4	33	2	15459319
Pubmed	Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.	BRD2 BRD4	5.23e-06	4	33	2	22912406
Pubmed	Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.	BRD2 BRD4	5.23e-06	4	33	2	24248598
Pubmed	HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold.	MLLT1 AFF4	5.23e-06	4	33	2	23251033
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	SETD1A KANK1 PRICKLE3 CWC22 NAF1	5.40e-06	270	33	5	24366813
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	CHD9 CHD8 SPEN BAZ2B CBX2	6.67e-06	282	33	5	23667531
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	RTF1 CHD8 SPEN BRD4 AFF4	6.78e-06	283	33	5	30585729
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	AFF1 PPIG BRD2 SPEN PRICKLE3 BRD4 NAF1	6.79e-06	774	33	7	15302935
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	SETD1A CHD8 SPEN BRD4	7.90e-06	134	33	4	25452129
Pubmed	Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression.	BRD2 BRD4	8.72e-06	5	33	2	24733848
Pubmed	NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.	CHD8 BRD4	8.72e-06	5	33	2	26626481
Pubmed	Intron 1-Mediated Regulation of EGFR Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins.	BRD2 BRD4	1.31e-05	6	33	2	31444232
Pubmed	Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription.	BRDT BRD4	1.31e-05	6	33	2	17690245
Pubmed	Misguided transcriptional elongation causes mixed lineage leukemia.	MLLT1 AFF1	1.31e-05	6	33	2	19956800
Pubmed	The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.	BRD2 JMJD6 BRD4	2.20e-05	57	33	3	21555454
Pubmed	BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail.	BRD2 BRD4	2.44e-05	8	33	2	31311807
Pubmed	Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.	MLLT1 AFF4	2.44e-05	8	33	2	21873227
Pubmed	Host cell factors stimulate HIV-1 transcription by antagonizing substrate-binding function of Siah1 ubiquitin ligase to stabilize transcription elongation factor ELL2.	AFF1 AFF4	2.44e-05	8	33	2	32479599
Pubmed	The ubiquitin ligase Siah1 controls ELL2 stability and formation of super elongation complexes to modulate gene transcription.	MLLT1 AFF4	2.44e-05	8	33	2	22483617
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	GPALPP1 SETD1A CHD8 PPIG NKTR ZCCHC10 CWC22 JMJD6	2.48e-05	1318	33	8	30463901
Pubmed	Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.	AFF1 AFF4	3.13e-05	9	33	2	24565118
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	SETD1A CHD9 CHD8 BRD2 BRD4	3.33e-05	394	33	5	27248496
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RTF1 CHD9 CHD8 PPIG BRD2 JMJD6 BRD4	3.86e-05	1014	33	7	32416067
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	RTF1 SETD1A CBX2	3.91e-05	69	33	3	28481362
Pubmed	Expression of Leukaemia associated transcription factor Af9/Mllt3 in the cerebral cortex of the mouse.	MLLT1 AFF1	3.91e-05	10	33	2	19000783
Pubmed	Analysis of the dynamics of limb transcriptomes during mouse development.	SOX4 AFF3	3.91e-05	10	33	2	21801425
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	CHD8 PPIG BRD2 BAZ2B BRD4	4.06e-05	411	33	5	35182466
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	NKTR KANK1 DCAF5 NAF1 CBX2 RPAP2	4.15e-05	689	33	6	36543142
Pubmed	The protein interaction landscape of the human CMGC kinase group.	RTF1 MLLT1 AFF1 PPIG AFF4 AFF3	4.36e-05	695	33	6	23602568
Pubmed	Human transcription factor protein interaction networks.	SOX4 MLLT1 SETD1A CHD8 BRD2 SPEN DCAF5 CBX2	4.41e-05	1429	33	8	35140242
Pubmed	Human mediator subunit MED26 functions as a docking site for transcription elongation factors.	MLLT1 AFF1 AFF4	4.63e-05	73	33	3	21729782
Pubmed	Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.	BRD2 BRD4	4.78e-05	11	33	2	28805820
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	CHD9 JMJD6 DCAF5 NAF1	5.82e-05	223	33	4	33187986
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CHD9 PPIG BRD2 SPEN CWC22 BRD4 AFF4	5.82e-05	1082	33	7	38697112
Pubmed	BET proteins are essential for the specification and maintenance of the epiblast lineage in mouse preimplantation embryos.	BRD2 BRD4	6.77e-05	13	33	2	35264162
Interaction	PLCD3 interactions	RTF1 GPALPP1 MLLT1 AFF1 SETD1A CHD9 CHD8 KANK1 FBXL19 BRD2 ZCCHC10 SPEN PRICKLE3 CWC22 DCAF5 BRD4 AFF4 NAF1	1.21e-32	121	32	18	int:PLCD3
Interaction	PIP4K2A interactions	RTF1 GPALPP1 MLLT1 AFF1 CHD9 CHD8 PPIG KANK1 BRD2 ZCCHC10 SPEN PRICKLE3 CWC22 JMJD6 BRD4 AFF4 NAF1 AFF3	7.01e-28	216	32	18	int:PIP4K2A
Interaction	CT45A5 interactions	NAP1L3 SETD1A CHD9 CHD8 KANK1 BRD2 SPEN CWC22 JMJD6 BRD4 AFF4 NAF1 RNF111	5.00e-24	78	32	13	int:CT45A5
Interaction	CAMKV interactions	GPALPP1 MLLT1 AFF1 CHD9 BRD2 ZCCHC10 SPEN PRICKLE3 CWC22 BRD4 AFF4 NAF1	1.87e-19	118	32	12	int:CAMKV
Interaction	NFKBIL1 interactions	NAP1L3 SETD1A CHD9 CHD8 PPIG BRD2 ZCCHC10 SPEN CWC22 JMJD6 AFF4	1.31e-18	93	32	11	int:NFKBIL1
Interaction	SYT2 interactions	RTF1 NAP1L3 MLLT1 SETD1A CHD9 KANK1 CWC22 JMJD6 DCAF5 AFF4 NAF1 AFF3	3.67e-18	150	32	12	int:SYT2
Interaction	EPB41L3 interactions	RTF1 MLLT1 AFF1 SETD1A CHD9 PPIG KANK1 ZCCHC10 PRICKLE3 CWC22 AFF4 NAF1	5.09e-15	272	32	12	int:EPB41L3
Interaction	SULF2 interactions	SETD1A CHD9 BRD2 ZCCHC10 SPEN CWC22 DCAF5 BRD4 NAF1	1.61e-13	119	32	9	int:SULF2
Interaction	EPB41L1 interactions	MLLT1 AFF1 SETD1A BRD2 ZCCHC10 PRICKLE3 CWC22 AFF4 NAF1	9.81e-12	187	32	9	int:EPB41L1
Interaction	DENND2D interactions	RTF1 MLLT1 FBXL19 BRD2 CWC22 AFF4	1.84e-11	36	32	6	int:DENND2D
Interaction	MDK interactions	SETD1A CHD9 PPIG BRD2 CWC22 AFF4 NAF1	9.29e-11	91	32	7	int:MDK
Interaction	DDX23 interactions	RTF1 GPALPP1 MLLT1 PPIG NKTR BRD2 BRDT CWC22 BRD4 AFF4 NAF1	1.03e-10	480	32	11	int:DDX23
Interaction	MED19 interactions	FBXL19 BRD2 BRDT JMJD6 BRD4 AFF4 RPAP2	2.75e-10	106	32	7	int:MED19
Interaction	MED26 interactions	MLLT1 AFF1 BRD2 ZCCHC10 BRD4 AFF4 RPAP2	2.94e-10	107	32	7	int:MED26
Interaction	EPB41L5 interactions	SETD1A CHD9 BRD2 ZCCHC10 PRICKLE3 CWC22 DCAF5 AFF4 NAF1	6.24e-10	298	32	9	int:EPB41L5
Interaction	NKAP interactions	CHD9 CHD8 PPIG NKTR BRD2 ZCCHC10 JMJD6	1.29e-09	132	32	7	int:NKAP
Interaction	PLCD4 interactions	NAP1L3 MLLT1 FBXL19 AFF4 CBX2	1.42e-09	32	32	5	int:PLCD4
Interaction	POLR1G interactions	RTF1 MLLT1 CHD9 CHD8 BRD2 BAZ2B BRD4 AFF4 CBX2 RPAP2	2.58e-09	489	32	10	int:POLR1G
Interaction	DHX8 interactions	RTF1 GPALPP1 NKTR ZCCHC10 SPEN CWC22 JMJD6 AFF4	1.37e-08	292	32	8	int:DHX8
Interaction	KCNE3 interactions	NAP1L3 FBXL19 BRD2 SPEN PRICKLE3 BRD4 NAF1 CBX2	1.53e-08	296	32	8	int:KCNE3
Interaction	TAF7 interactions	CHD8 BRD2 ZCCHC10 BRDT JMJD6 BRD4	1.67e-08	108	32	6	int:TAF7
Interaction	CHD8 interactions	SETD1A CHD8 PPIG BRD2 BRDT BRD4 NAF1	1.82e-08	193	32	7	int:CHD8
Interaction	BRD9 interactions	BRD2 ZCCHC10 CWC22 JMJD6 BRD4 NAF1	2.70e-08	117	32	6	int:BRD9
Interaction	FAM9A interactions	NAP1L3 CWC22 JMJD6 AFF4 NAF1	3.43e-08	59	32	5	int:FAM9A
Interaction	CDK12 interactions	MLLT1 ZCCHC10 SPEN CWC22 BRD4 AFF4 RNF111	5.72e-08	228	32	7	int:CDK12
Interaction	DAXX interactions	SETD1A CHD9 BRD2 ZCCHC10 SPEN AFF4 NAF1 CBX2	5.97e-08	353	32	8	int:DAXX
Interaction	CACTIN interactions	BRD2 ZCCHC10 SPEN CWC22 JMJD6 BRD4	9.32e-08	144	32	6	int:CACTIN
Interaction	CSNK2A1 interactions	RTF1 MLLT1 SETD1A NKTR BRD2 ZCCHC10 JMJD6 BRD4 NAF1 RNF111 CBX2	1.33e-07	956	32	11	int:CSNK2A1
Interaction	PIP4K2C interactions	RTF1 BRD2 ZCCHC10 PRICKLE3 BRD4 AFF4	1.68e-07	159	32	6	int:PIP4K2C
Interaction	NKAPD1 interactions	GPALPP1 PPIG NKTR ZCCHC10 CWC22 JMJD6	1.81e-07	161	32	6	int:NKAPD1
Interaction	FGF12 interactions	RTF1 MLLT1 AFF1 CHD9 AFF4	2.45e-07	87	32	5	int:FGF12
Interaction	FGF11 interactions	RTF1 SETD1A CHD9 DCAF5 BRD4 RPAP2	2.49e-07	170	32	6	int:FGF11
Interaction	MED14 interactions	RTF1 FBXL19 ZCCHC10 JMJD6 BRD4 RPAP2	2.58e-07	171	32	6	int:MED14
Interaction	NUP43 interactions	RTF1 GPALPP1 SETD1A CHD9 CHD8 NKTR SPEN CWC22 BAZ2B	3.71e-07	625	32	9	int:NUP43
Interaction	GRK5 interactions	PPIG KANK1 CWC22 DCAF5 AFF4 NAF1	3.72e-07	182	32	6	int:GRK5
Interaction	PNN interactions	GPALPP1 PPIG NKTR BRD2 BRDT CWC22 BRD4	3.86e-07	302	32	7	int:PNN
Interaction	KMT2A interactions	RTF1 MLLT1 AFF1 SETD1A CHD8 BRD4 AFF4	5.02e-07	314	32	7	int:KMT2A
Interaction	JMJD6 interactions	PPIG BRD2 ZCCHC10 JMJD6 BRD4 NAF1	7.48e-07	205	32	6	int:JMJD6
Interaction	NSD3 interactions	SOX4 CHD8 BRD2 BRDT BRD4	1.08e-06	117	32	5	int:NSD3
Interaction	SP110 interactions	MLLT1 DCAF5 BRD4 AFF4 NAF1	1.32e-06	122	32	5	int:SP110
Interaction	MLLT1 interactions	MLLT1 AFF1 BRD4 AFF4 AFF3	1.38e-06	123	32	5	int:MLLT1
Interaction	C1orf226 interactions	BRD2 ZCCHC10 BRD4 NAF1	1.45e-06	53	32	4	int:C1orf226
Interaction	MED31 interactions	FBXL19 JMJD6 BRD4 NAF1 RPAP2	1.49e-06	125	32	5	int:MED31
Interaction	PPIG interactions	CHD8 PPIG ZCCHC10 JMJD6 BRD4	1.61e-06	127	32	5	int:PPIG
Interaction	COIL interactions	RTF1 MLLT1 CHD9 CHD8 BRD2 ZCCHC10 BAZ2B AFF4	1.77e-06	552	32	8	int:COIL
Interaction	ZNF816 interactions	GPALPP1 NKTR DCAF5	2.01e-06	16	32	3	int:ZNF816
Interaction	SLX4 interactions	MLLT1 CHD9 CHD8 BRD2 BAZ2B BRD4 AFF4 AFF3	2.31e-06	572	32	8	int:SLX4
Interaction	ANKRD36B interactions	CHD9 CHD8 ZCCHC10 SPEN	2.40e-06	60	32	4	int:ANKRD36B
Interaction	NOVA2 interactions	BRD2 BRDT BRD4	2.44e-06	17	32	3	int:NOVA2
Interaction	PSME3 interactions	CHD8 FBXL19 RPH3AL ZCCHC10 BRD4 RNF111 CBX2	2.44e-06	398	32	7	int:PSME3
Interaction	CCNT2 interactions	MLLT1 BRDT BRD4 AFF4	2.74e-06	62	32	4	int:CCNT2
Interaction	PES1 interactions	SETD1A BRD2 CWC22 BRD4 AFF4 NAF1	2.85e-06	258	32	6	int:PES1
Interaction	PWWP2B interactions	BRD2 BRDT BRD4	2.92e-06	18	32	3	int:PWWP2B
Interaction	SNIP1 interactions	RTF1 GPALPP1 PPIG NKTR BRD2 ZCCHC10 CWC22	3.32e-06	417	32	7	int:SNIP1
Interaction	AFF1 interactions	MLLT1 AFF1 BRD4 AFF4	3.52e-06	66	32	4	int:AFF1
Interaction	BRD2 interactions	RTF1 CHD8 BRD2 BRDT JMJD6 BRD4 RNF111	4.01e-06	429	32	7	int:BRD2
Interaction	CSNK2B interactions	CHD8 NKTR BRD2 BRDT BAZ2B BRD4 RNF111 CBX2	4.45e-06	625	32	8	int:CSNK2B
Interaction	ARRB2 interactions	RTF1 MLLT1 NKTR KANK1 BRD2 BRD4 AFF4	5.81e-06	454	32	7	int:ARRB2
Interaction	DDX41 interactions	BRD2 SPEN CWC22 JMJD6 BRD4	6.00e-06	166	32	5	int:DDX41
Interaction	TWIST1 interactions	CHD9 CHD8 SPEN BRD4 CBX2	6.74e-06	170	32	5	int:TWIST1
Interaction	H3C1 interactions	MLLT1 SETD1A CHD8 BRD2 SPEN JMJD6 BRD4 AFF4 CBX2	7.59e-06	901	32	9	int:H3C1
Interaction	BRDT interactions	CHD8 BRD2 BRDT BRD4	7.99e-06	81	32	4	int:BRDT
Interaction	ELL3 interactions	MLLT1 AFF1 AFF4	9.22e-06	26	32	3	int:ELL3
Interaction	MED30 interactions	FBXL19 BRD2 BRD4 RPAP2	9.24e-06	84	32	4	int:MED30
Interaction	MLLT3 interactions	MLLT1 AFF1 AFF4 AFF3	9.68e-06	85	32	4	int:MLLT3
Interaction	MED22 interactions	BRD2 ZCCHC10 BRD4 RPAP2	9.68e-06	85	32	4	int:MED22
Interaction	TAF5 interactions	SOX4 BRD2 ZCCHC10 BRDT	1.01e-05	86	32	4	int:TAF5
Interaction	H3C3 interactions	CHD8 BRD2 SPEN BAZ2B BRD4 AFF4 CBX2	1.02e-05	495	32	7	int:H3C3
Interaction	PIP4K2B interactions	BRD2 ZCCHC10 PRICKLE3 BRD4	1.57e-05	96	32	4	int:PIP4K2B
Interaction	POLR1E interactions	MLLT1 CHD8 BRD2 BAZ2B BRD4 RPAP2	1.63e-05	350	32	6	int:POLR1E
Interaction	H3-3A interactions	SETD1A CHD9 CHD8 BRD2 SPEN BRD4 AFF4 CBX2	1.67e-05	749	32	8	int:H3-3A
Interaction	SMC5 interactions	MLLT1 CHD8 BRD2 SPEN CWC22 BAZ2B BRD4 AFF4 CBX2	1.75e-05	1000	32	9	int:SMC5
Interaction	MED6 interactions	FBXL19 ZCCHC10 BRD4 RPAP2	1.92e-05	101	32	4	int:MED6
Interaction	ELL2 interactions	MLLT1 AFF1 AFF4	1.92e-05	33	32	3	int:ELL2
Interaction	MED29 interactions	FBXL19 BRD2 ZCCHC10 BRD4	1.99e-05	102	32	4	int:MED29
Interaction	MED27 interactions	FBXL19 ZCCHC10 BRD4 RPAP2	1.99e-05	102	32	4	int:MED27
Interaction	TERF2IP interactions	RTF1 SETD1A CHD8 SPEN BRD4 AFF4 CBX2	2.07e-05	552	32	7	int:TERF2IP
Interaction	CHST5 interactions	SETD1A CWC22 NAF1	2.10e-05	34	32	3	int:CHST5
Interaction	DACH1 interactions	SOX4 PPIG ZCCHC10 BRDT	2.15e-05	104	32	4	int:DACH1
Interaction	CCNT1 interactions	MLLT1 AFF1 BRDT BRD4 AFF4	2.61e-05	225	32	5	int:CCNT1
Interaction	H2BC8 interactions	RTF1 GPALPP1 CHD8 BRD2 SPEN BRD4 CBX2	2.72e-05	576	32	7	int:H2BC8
Interaction	HMGXB4 interactions	BRD2 ZCCHC10 JMJD6 BRD4	2.99e-05	113	32	4	int:HMGXB4
Interaction	EDA interactions	SETD1A CWC22 AFF4 NAF1	2.99e-05	113	32	4	int:EDA
Interaction	NOS1AP interactions	BRD2 ZCCHC10 BRD4 NAF1	2.99e-05	113	32	4	int:NOS1AP
Interaction	CTR9 interactions	RTF1 SOX4 BRD4 AFF4 NAF1	3.09e-05	233	32	5	int:CTR9
Interaction	VANGL1 interactions	FBXL19 BRD2 ZCCHC10 PRICKLE3 NAF1	3.15e-05	234	32	5	int:VANGL1
Interaction	TSPYL1 interactions	NAP1L3 BRD2 ZCCHC10 RNF111	3.31e-05	116	32	4	int:TSPYL1
Interaction	APOC3 interactions	SOX4 BRD4 RPAP2	3.45e-05	40	32	3	int:APOC3
Interaction	H2BC3 interactions	SETD1A CHD9 CHD8 BRD2 BRD4 CBX2	3.75e-05	406	32	6	int:H2BC3
Interaction	MED8 interactions	FBXL19 ZCCHC10 BRD4 RPAP2	3.90e-05	121	32	4	int:MED8
Interaction	TAF6 interactions	SETD1A BRD2 ZCCHC10 BRDT BRD4	3.93e-05	245	32	5	int:TAF6
Interaction	DHX40 interactions	RTF1 BRD2 BRDT JMJD6 BRD4	4.24e-05	249	32	5	int:DHX40
Interaction	STAC3 interactions	ZCCHC10 JMJD6 BAZ2B	4.30e-05	43	32	3	int:STAC3
Interaction	MAD2L1 interactions	SETD1A CHD9 CHD8 DCAF5 BRD4	4.49e-05	252	32	5	int:MAD2L1
Interaction	MED24 interactions	FBXL19 BRD2 BRD4 RPAP2	4.86e-05	128	32	4	int:MED24
Interaction	EAF1 interactions	MLLT1 AFF1 AFF4 NAF1	4.86e-05	128	32	4	int:EAF1
Interaction	SNRNP40 interactions	GPALPP1 NKTR SPEN CWC22 BAZ2B BRD4 CBX2	5.15e-05	637	32	7	int:SNRNP40
Interaction	MED15 interactions	RTF1 FBXL19 BRD4 RPAP2	5.32e-05	131	32	4	int:MED15
Interaction	CBX3 interactions	RTF1 SETD1A CHD9 CHD8 BRD2 SPEN BRD4	5.63e-05	646	32	7	int:CBX3
Interaction	PRPF40A interactions	PPIG ZCCHC10 SPEN CWC22 JMJD6 BRD4	6.32e-05	446	32	6	int:PRPF40A
Cytoband	1p22.1	BRDT RPAP2	2.45e-04	32	33	2	1p22.1
Cytoband	Ensembl 112 genes in cytogenetic band chr1p22	BRDT RPAP2	4.39e-03	137	33	2	chr1p22
Cytoband	Ensembl 112 genes in cytogenetic band chr2q31	PPIG CWC22	7.29e-03	178	33	2	chr2q31
Cytoband	16p11.2	SETD1A FBXL19	8.35e-03	191	33	2	16p11.2
GeneFamily	AF4/FMR2 family\|Super elongation complex	MLLT1 AFF1 AFF4 AFF3	1.09e-10	9	19	4	1280
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF1 AFF4 AFF3	3.93e-09	4	19	3	1145
GeneFamily	Cyclophilin peptidylprolyl isomerases	PPIG NKTR	1.77e-04	19	19	2	909
GeneFamily	PHD finger proteins	FBXL19 BAZ2B	3.97e-03	90	19	2	88
GeneFamily	RNA binding motif containing	SETD1A SPEN	2.07e-02	213	19	2	725
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	SOX4 NKTR SPEN BAZ2B	4.34e-06	90	32	4	M39250
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	AFF1 CHD9 KANK1 SPEN BAZ2B	2.97e-05	300	32	5	M8702
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	MLLT1 AFF1 BRD4 AFF4 AFF3	4.22e-05	323	32	5	M9150
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	PPIG NKTR ZCCHC10 AFF4 AFF3	7.34e-05	363	32	5	M41103
Coexpression	GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN	NAP1L3 CHD9 KANK1 AFF3	9.44e-05	197	32	4	M10015
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	CHD8 BRD4 AFF4 CBX2	9.81e-05	199	32	4	M7254
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN	AFF1 NKTR BRD4 AFF4	1.00e-04	200	32	4	M9472
Coexpression	GSE17721_POLYIC_VS_CPG_6H_BMDC_UP	BRDT SPEN CWC22 CBX2	1.00e-04	200	32	4	M3943
Coexpression	BUSSLINGER_DUODENAL_TUFT_CELLS	SOX4 CHD9 BRD4	1.32e-04	81	32	3	M40033
Coexpression	CHEN_HOXA5_TARGETS_9HR_UP	CHD9 PPIG ZCCHC10 RNF111	1.52e-04	223	32	4	M17621
CoexpressionAtlas	kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#2_top-relative-expression-ranked_1000	SOX4 SETD1A CWC22 NAF1 RNF111	6.21e-06	176	32	5	gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k2_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	SOX4 SETD1A CHD9 CHD8 NKTR BRD2 BAZ2B AFF3	1.86e-05	801	32	8	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	NAP1L3 SOX4 SETD1A CHD9 CHD8 NKTR BRD2 JMJD6	2.11e-05	815	32	8	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	SOX4 MLLT1 CHD8 FBXL19 BRD2 JMJD6 BAZ2B CBX2	2.69e-05	843	32	8	gudmap_developingGonad_e11.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	SOX4 MLLT1 CHD8 FBXL19 BRD2 JMJD6 BAZ2B CBX2	2.71e-05	844	32	8	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	SOX4 SETD1A CHD9 CHD8 NKTR AFF3	2.72e-05	404	32	6	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	SOX4 SETD1A CHD9 CHD8 NKTR AFF3	2.80e-05	406	32	6	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500	SETD1A CHD9 NKTR AFF3	7.76e-05	152	32	4	gudmap_developingGonad_e18.5_epididymis_500_k4
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	NAP1L3 SETD1A CHD9 CHD8 NKTR	1.13e-04	323	32	5	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	SOX4 SETD1A CHD9 CHD8 NKTR BRD2 AFF3	1.43e-04	790	32	7	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	SOX4 SETD1A CHD9 CHD8 NKTR BRD2 AFF3	1.51e-04	797	32	7	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	SOX4 SETD1A CHD9 CHD8 NKTR BRD2 AFF3	1.54e-04	799	32	7	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	SOX4 SETD1A CHD9 CHD8 NKTR BRD2 BRDT	1.62e-04	806	32	7	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000	SOX4 MLLT1 CHD8 BRD2 JMJD6 BAZ2B CBX2	1.79e-04	819	32	7	gudmap_developingGonad_e12.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000	SOX4 CHD8 BRD2 BRDT JMJD6 BAZ2B CBX2	1.83e-04	822	32	7	gudmap_developingGonad_e14.5_ testes_1000
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500	SOX4 CHD8 BRD2 BAZ2B CBX2	3.28e-04	406	32	5	gudmap_developingGonad_e12.5_testes_500
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500	SOX4 BRD2 BRDT BAZ2B CBX2	3.47e-04	411	32	5	gudmap_developingGonad_e14.5_ testes_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	SETD1A CHD9 CHD8 NKTR	3.50e-04	225	32	4	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	SOX4 SETD1A CHD9 CHD8 NKTR	3.55e-04	413	32	5	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	SETD1A CHD9 CHD8 NKTR	3.80e-04	230	32	4	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500	SOX4 MLLT1 BRD2 BAZ2B CBX2	4.50e-04	435	32	5	gudmap_developingGonad_e11.5_testes and mesonephros_500
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	SETD1A CHD9 NKTR AFF3	5.13e-04	249	32	4	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500	SETD1A CHD8 NKTR	5.55e-04	107	32	3	gudmap_developingGonad_e14.5_ epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	SETD1A CHD9 CHD8 NKTR	7.44e-04	275	32	4	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	SETD1A CHD9 NKTR AFF3	8.06e-04	281	32	4	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	SOX4 MLLT1 FBXL19 JMJD6 CBX2	8.30e-04	498	32	5	gudmap_developingGonad_e11.5_testes_k5_1000
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000	SOX4 MLLT1 JMJD6 BAZ2B CBX2	1.04e-03	524	32	5	gudmap_developingGonad_e12.5_testes_k1_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	SETD1A CHD9 CHD8 NKTR BRD2 BRDT	1.06e-03	795	32	6	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	SOX4 MLLT1 FBXL19 JMJD6 CBX2	1.12e-03	533	32	5	gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	SOX4 CHD9 PPIG CWC22 BRD4 TMEM40 NAF1 CBX2	1.20e-03	1468	32	8	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000	SETD1A CHD8 NKTR	1.50e-03	151	32	3	gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000	SOX4 BRD2 JMJD6	1.65e-03	156	32	3	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SOX4 CHD9 CHD8 BAZ2B AFF4	2.28e-07	183	33	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTF1 SOX4 PPIG BRD2 BRD4	2.61e-07	188	33	5	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOX4 NKTR BAZ2B AFF4	9.06e-06	179	33	4	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19_Mild-NK_CD56bright\|COVID-19_Mild / Disease condition and Cell class	SOX4 CHD9 BAZ2B AFF3	9.06e-06	179	33	4	90e7a4af195aa2332b07a9f06cde63e72ff49255
ToppCell	Control-NK_CD56bright\|Control / Disease condition and Cell class	SOX4 CHD9 BAZ2B AFF3	1.22e-05	193	33	4	8b1e7a226a6057e1097c1525984127b54e823876
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	RTF1 PPIG JMJD6 BRD4	1.35e-05	198	33	4	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	RTF1 PPIG BAZ2B BRD4	1.37e-05	199	33	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	RTF1 PPIG BRD4	1.44e-04	138	33	3	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Mesoderm\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	PRICKLE3 TMEM40 NAF1	1.47e-04	139	33	3	d441c29852c28928ecb696b4b95e31b30c17116b
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SOX4 KANK1 TMEM40	1.84e-04	150	33	3	70ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|390C / Donor, Lineage, Cell class and subclass (all cells)	NAP1L3 FBXL19 PRICKLE3	2.03e-04	155	33	3	afdd0aba0f3788c2fb916ffb453c5dd7cde2304c
ToppCell	BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KANK1 FBXL19 RPAP2	2.07e-04	156	33	3	5d9e1df70f2e9219f6b029be2e39297605d36726
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NAP1L3 SOX4 CBX2	2.31e-04	162	33	3	233011408f022647932c81ebab78f9813e3c6833
ToppCell	facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 RPH3AL TMEM40	2.52e-04	167	33	3	a4a795751644b22af616335379e64ae95175180c
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|368C / Donor, Lineage, Cell class and subclass (all cells)	SOX4 SPEN AFF3	2.61e-04	169	33	3	0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74
ToppCell	Mild/Remission-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SOX4 BAZ2B AFF3	2.80e-04	173	33	3	694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCell	3'_v3-blood-Mast-Mast_cells\|blood / Manually curated celltypes from each tissue	AFF1 PRICKLE3 CBX2	2.95e-04	176	33	3	b9da3deaf62622d47eb30b6be7548253eee95597
ToppCell	severe-Others-CD34+_GATA2+_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NAP1L3 SOX4 CBX2	3.09e-04	179	33	3	dd789a1b7327d6f9ed5272f3eb54bd43f7ae8d78
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 KANK1 TMEM40	3.20e-04	181	33	3	4e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 KANK1 TMEM40	3.20e-04	181	33	3	ad30c01290fb98adbd0caed301a584761212c977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 KANK1 TMEM40	3.20e-04	181	33	3	3a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 BAZ2B AFF4	3.25e-04	182	33	3	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	Bac-SEP-Myeloid-pDC\|Bac-SEP / Disease, Lineage and Cell Type	SOX4 CHD9 AFF3	3.41e-04	185	33	3	3de50b2042f22b0fb62ff12c76d85cc67649a0bd
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	CHD9 NKTR BAZ2B	3.41e-04	185	33	3	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	BRD2 JMJD6 NAF1	3.46e-04	186	33	3	35f32fc2761435356c8f54b5bb2f026b8c070efe
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTF1 PPIG BRD2	3.52e-04	187	33	3	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	hematopoetic_progenitors-CD34+_HSC\|World / Lineage and Cell class	NAP1L3 SOX4 CBX2	3.63e-04	189	33	3	51ff31c9cf5eff98ad01c0455dc4ae4908713575
ToppCell	COVID-19_Severe-HSPC\|COVID-19_Severe / disease group, cell group and cell class	NAP1L3 SOX4 CBX2	3.63e-04	189	33	3	96015439971e2e5b8d6294ca5a6b873c7774e925
ToppCell	COVID-19_Severe-HSPC\|World / disease group, cell group and cell class	NAP1L3 SOX4 CBX2	3.63e-04	189	33	3	555c0b13f1508b9e3712b36d77144e73e828bc76
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF1 CHD9 AFF3	3.63e-04	189	33	3	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	NKTR SPEN RNF111	3.74e-04	191	33	3	9454f642c3621370fa23640b631301346b300950
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	KANK1 RPH3AL AFF3	3.80e-04	192	33	3	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	facs-Skin-Telogen-3m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF1 KANK1 AFF4	3.92e-04	194	33	3	ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 CHD9 AFF3	3.92e-04	194	33	3	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	facs-Skin-Telogen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF1 KANK1 AFF4	3.92e-04	194	33	3	bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6
ToppCell	facs-Skin-Telogen-3m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF1 KANK1 AFF4	3.92e-04	194	33	3	4d7fc4d0a55abb3b645116d13a983bbedc55f70c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 AFF1 AFF3	3.92e-04	194	33	3	3a1f95639d5f239f001bd67d4213e8938e7f299d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KANK1 RPH3AL AFF3	3.92e-04	194	33	3	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 AFF1 AFF3	3.92e-04	194	33	3	11709704079f24a730476572dc2f01e9d2226e2c
ToppCell	Mild/Remission-B_naive-8\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SOX4 BAZ2B AFF3	3.97e-04	195	33	3	0a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCell	Control-B_naive-8\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SOX4 BAZ2B AFF3	4.03e-04	196	33	3	54074da84000e4749ade8acc542f05a275bf829f
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SOX4 BRD2 AFF3	4.03e-04	196	33	3	9a6e4eea19348a6e3379d3b872456ab6280cb74f
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	SOX4 CHD9 BAZ2B	4.03e-04	196	33	3	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	SOX4 CHD9 BAZ2B	4.03e-04	196	33	3	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RTF1 PPIG NKTR	4.09e-04	197	33	3	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	BRD2 JMJD6 NAF1	4.09e-04	197	33	3	cd54e6ad175529327fa0372033016b3b978dd452
ToppCell	Control-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SOX4 BAZ2B AFF3	4.09e-04	197	33	3	925bf0d38e4ce279fa45f455546ebd199282c0df
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SOX4 BRD2 AFF3	4.16e-04	198	33	3	5f465cf5c7493e32d9afe9e9d05757d0a95acc33
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SOX4 BRD2 AFF3	4.16e-04	198	33	3	77ce3fe1ab161c0faf8987e73a64ab61294b9255
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	SOX4 CHD9 BAZ2B	4.16e-04	198	33	3	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	RTF1 PPIG BRD4	4.22e-04	199	33	3	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SOX4 MLLT1 CHD9	4.22e-04	199	33	3	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SOX4 BRD2 AFF3	4.22e-04	199	33	3	dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	RTF1 PPIG BRD4	4.22e-04	199	33	3	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	COVID-19-COVID-19_Severe-Others-HSPC\|COVID-19_Severe / Disease, condition lineage and cell class	NAP1L3 SOX4 CBX2	4.22e-04	199	33	3	25de67b6c9c8d6bb9a538e071a40ef865906c95d
ToppCell	Control-Control-Others-HSPC\|Control / Disease, condition lineage and cell class	NAP1L3 SOX4 CBX2	4.22e-04	199	33	3	b71169be0d916b2ed139a3122d78bb154c71edb4
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	PPIG BAZ2B BRD4	4.22e-04	199	33	3	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	AFF1 BAZ2B AFF3	4.22e-04	199	33	3	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Sepsis-Bac-SEP-Myeloid-pDC\|Bac-SEP / Disease, condition lineage and cell class	SOX4 CHD9 AFF3	4.22e-04	199	33	3	7f6569de050262f3d8d9d41c0f0cc139de85c0cb
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	RTF1 PPIG BRD4	4.22e-04	199	33	3	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	NAP1L3 SOX4 AFF3	4.28e-04	200	33	3	e9eb348a66011d8aace4331f84690ae27cb0d061
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Cortical_neuron\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	NAP1L3 SOX4 AFF3	4.28e-04	200	33	3	458fb0f40c1720f1cacedf78c40bd059692bfc62
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SOX4 PPIG NKTR SPEN BRD4	5.34e-06	177	33	5	985_DN
Drug	AC1NRAEN	BRD2 BRDT BRD4	1.10e-05	30	33	3	CID005287841
Drug	nitrosocimetidine	CWC22 DSPP	2.03e-05	5	33	2	CID000052445
Drug	thioglycerol	RPH3AL CWC22 RNF111	3.29e-05	43	33	3	CID000007291
Drug	folpet	CWC22 DSPP	5.67e-05	8	33	2	CID000008607
Drug	flubendazole	PPIG DSPP	5.67e-05	8	33	2	CID000035802
Drug	teucrin A	PPIG SPEN	7.29e-05	9	33	2	CID000159529
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	SOX4 PPIG NKTR SPEN	1.26e-04	179	33	4	4585_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	GPALPP1 CHD9 SPEN RNF111	1.35e-04	182	33	4	3887_DN
Drug	staurosporine; Down 200; 0.1uM; MCF7; HG-U133A	SOX4 JMJD6 BRD4 RNF111	1.41e-04	184	33	4	423_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SOX4 NKTR SPEN BRD4	1.44e-04	185	33	4	1673_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	SOX4 NKTR SPEN JMJD6	1.56e-04	189	33	4	1045_DN
Drug	testosterone enanthate	SOX4 CHD8 PPIG NKTR BRD2 SPEN	1.57e-04	575	33	6	ctd:C004648
Drug	dimethylthioarsinic acid	AFF1 AFF4	1.57e-04	13	33	2	ctd:C547156
Drug	Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A	RTF1 PPIG NKTR KANK1	1.76e-04	195	33	4	1956_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; HL60; HT_HG-U133A	SOX4 SETD1A JMJD6 RPAP2	1.79e-04	196	33	4	1311_UP
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A	GPALPP1 BRD4 AFF4 RPAP2	1.83e-04	197	33	4	1526_DN
Drug	methyl p-tolyl sulfide	PPIG DSPP	1.83e-04	14	33	2	CID000069334
Drug	Caffeic acid [3331-39-5]; Down 200; 22.2uM; HL60; HT_HG-U133A	AFF1 PRICKLE3 DSPP AFF3	1.86e-04	198	33	4	3053_DN
Drug	phenformin hydrochloride; Down 200; 10uM; MCF7; HG-U133A	SOX4 SETD1A SPEN TMEM40	1.86e-04	198	33	4	21_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	SOX4 CHD8 NKTR RPH3AL	1.86e-04	198	33	4	4567_DN
Drug	Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; HL60; HG-U133A	SOX4 AFF1 NKTR TMEM40	1.86e-04	198	33	4	1574_UP
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; HL60; HG-U133A	RTF1 SOX4 CHD9 BAZ2B	1.90e-04	199	33	4	1737_DN
Drug	Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A	RTF1 RPH3AL BRD4 AFF4	1.90e-04	199	33	4	7355_DN
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	RTF1 SOX4 NKTR AFF4	1.90e-04	199	33	4	1484_DN
Drug	Cyproterone acetate [427-51-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RTF1 GPALPP1 CHD9 PRICKLE3	1.90e-04	199	33	4	6806_DN
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	GPALPP1 NKTR AFF4 RNF111	1.90e-04	199	33	4	1469_DN
Drug	Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PRICKLE3 JMJD6 BAZ2B BRD4	1.94e-04	200	33	4	5319_DN
Drug	AC1NOXKO	PPIG BRD2	2.11e-04	15	33	2	CID005120672
Disease	CHARGE syndrome (implicated_via_orthology)	CHD9 CHD8	2.38e-05	7	32	2	DOID:0050834 (implicated_via_orthology)
Disease	Facies	CHD8 AFF4	5.10e-05	10	32	2	C0282631
Disease	Intellectual Disability	SOX4 SETD1A CHD8 BRD4 AFF3	1.12e-04	447	32	5	C3714756
Disease	type 2 diabetes mellitus (implicated_via_orthology)	AFF1 AFF4 AFF3	2.01e-04	105	32	3	DOID:9352 (implicated_via_orthology)
Disease	melanoma (is_marker_for)	BRD2 BRD4	5.89e-04	33	32	2	DOID:1909 (is_marker_for)
Disease	Mitral valve prolapse	MEIOSIN TMEM40	7.01e-04	36	32	2	HP_0001634
Disease	mean platelet volume	AFF1 CHD9 PRICKLE3 CWC22 DCAF5 AFF3	7.05e-04	1020	32	6	EFO_0004584
Disease	Adult Medulloblastoma	BRD2 BRD4	1.00e-03	43	32	2	C0278876
Disease	Childhood Medulloblastoma	BRD2 BRD4	1.00e-03	43	32	2	C0278510
Disease	Melanotic medulloblastoma	BRD2 BRD4	1.00e-03	43	32	2	C1275668
Disease	Medullomyoblastoma	BRD2 BRD4	1.00e-03	43	32	2	C0205833
Disease	Desmoplastic Medulloblastoma	BRD2 BRD4	1.00e-03	43	32	2	C0751291
Disease	Congenital Heart Defects	BRD4 AFF4	1.05e-03	44	32	2	C0018798
Disease	Gastric Adenocarcinoma	BRD2 BRDT	1.10e-03	45	32	2	C0278701
Disease	Salivary Gland Neoplasms	SOX4 SPEN	1.19e-03	47	32	2	C0036095
Disease	Medulloblastoma	BRD2 BRD4	1.35e-03	50	32	2	C0025149
Disease	congenital heart disease (implicated_via_orthology)	CHD9 CHD8	2.55e-03	69	32	2	DOID:1682 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	AFF1 CHD9 FBXL19 ZCCHC10 DCAF5	2.83e-03	914	32	5	EFO_0004532
Disease	Glioblastoma	BRD2 BRD4	3.33e-03	79	32	2	C0017636
Disease	age of onset of asthma	AFF3 RPAP2	3.33e-03	79	32	2	OBA_2001001
Disease	Graves disease	SETD1A FBXL19	3.50e-03	81	32	2	EFO_0004237
Disease	Giant Cell Glioblastoma	BRD2 BRD4	3.76e-03	84	32	2	C0334588
Disease	alpha fetoprotein measurement	AFF1 CHD9	5.28e-03	100	32	2	EFO_0010583

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSSSSSDSESSSGSD	AFF3	421	P51826
SSSSSSSSSTDESED	CHD8	2086	Q9HCK8
SDSSSDSSSDSDSST	BRD4	486	O60885
ESSSSDLSSSDSSDS	BRDT	651	Q58F21
SSSNSDSDSGTSSDT	BAZ2B	241	Q9UIF8
KSDSSDSDSSDSSNS	DSPP	546	Q9NZW4
DSDSSDSSNSSDSSD	DSPP	551	Q9NZW4
DSSNSSDSSDSSDSD	DSPP	556	Q9NZW4
SDSSDSSDSDSSDSN	DSPP	561	Q9NZW4
SSDSDSSDSNSSSDS	DSPP	566	Q9NZW4
SSDSNSSSDSDSSDS	DSPP	571	Q9NZW4
SSSDSDSSDSDSSDS	DSPP	576	Q9NZW4
DSSDSDSSDSSDSDS	DSPP	581	Q9NZW4
DSSDSSDSDSSDSSN	DSPP	586	Q9NZW4
SDSDSSDSSNSSDSS	DSPP	591	Q9NZW4
SDSSNSSDSSDSSDS	DSPP	596	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	601	Q9NZW4
DSSDSSDSSDSSDSS	DSPP	606	Q9NZW4
SDSSDSSDSSDSKSD	DSPP	611	Q9NZW4
SDSSDSDSKSDSSDS	DSPP	631	Q9NZW4
SDSKSDSSDSNSSDS	DSPP	636	Q9NZW4
DSSDSNSSDSSDNSD	DSPP	641	Q9NZW4
NSSDSSDNSDSSDSS	DSPP	646	Q9NZW4
SDNSDSSDSSNSSNS	DSPP	651	Q9NZW4
SSDSSNSSNSSDSSD	DSPP	656	Q9NZW4
NSSNSSDSSDSSDSS	DSPP	661	Q9NZW4
SDSSDSSDSSDSSSS	DSPP	666	Q9NZW4
SSDSSDSSSSSDSSN	DSPP	671	Q9NZW4
DSSSSSDSSNSSDSS	DSPP	676	Q9NZW4
SDSSNSSDSSDSSDS	DSPP	681	Q9NZW4
SSDSSDSSDSSNSSE	DSPP	686	Q9NZW4
DSSDSSNSSESSDSS	DSPP	691	Q9NZW4
SNSSESSDSSDSSDS	DSPP	696	Q9NZW4
SSDSSDSSDSDSSDS	DSPP	701	Q9NZW4
DSSDSDSSDSSDSSN	DSPP	706	Q9NZW4
DSSDSSDSSNSNSSD	DSPP	711	Q9NZW4
SDSSNSNSSDSDSSN	DSPP	716	Q9NZW4
SNSSDSDSSNSSDSS	DSPP	721	Q9NZW4
SDSSNSSDSSDSSNS	DSPP	726	Q9NZW4
SSDSSDSSNSSDSSD	DSPP	731	Q9NZW4
DSSNSSDSSDSSDSS	DSPP	736	Q9NZW4
SDSSDSSDSSNSSDS	DSPP	741	Q9NZW4
SSDSSNSSDSSDSSD	DSPP	746	Q9NZW4
NSSDSSDSSDSSNSS	DSPP	751	Q9NZW4
SDSSDSSNSSDSSDS	DSPP	756	Q9NZW4
SSNSSDSSDSSDSSD	DSPP	761	Q9NZW4
DSSDSSDSSDSSDSS	DSPP	766	Q9NZW4
SDSSDSSDSSNSSDS	DSPP	771	Q9NZW4
SSDSSNSSDSNDSSN	DSPP	776	Q9NZW4
NSSDSNDSSNSSDSS	DSPP	781	Q9NZW4
NDSSNSSDSSDSSNS	DSPP	786	Q9NZW4
SSDSSDSSNSSDSSN	DSPP	791	Q9NZW4
DSSNSSDSSNSSDSS	DSPP	796	Q9NZW4
SDSSNSSDSSDSSDS	DSPP	801	Q9NZW4
SSDSSDSSDSSDSDS	DSPP	806	Q9NZW4
DSSDSSDSDSSNSSD	DSPP	811	Q9NZW4
SDSDSSNSSDSSNSS	DSPP	816	Q9NZW4
SNSSDSSNSSDSSDS	DSPP	821	Q9NZW4
SSNSSDSSDSSNSSD	DSPP	826	Q9NZW4
DSSDSSNSSDSSDSS	DSPP	831	Q9NZW4
SNSSDSSDSSDSSDG	DSPP	836	Q9NZW4
SSDSSDSSDGSDSDS	DSPP	841	Q9NZW4
SDSDSSNRSDSSNSS	DSPP	851	Q9NZW4
SNRSDSSNSSDSSDS	DSPP	856	Q9NZW4
SSNSSDSSDSSDSSN	DSPP	861	Q9NZW4
DSSDSSDSSNSSDSS	DSPP	866	Q9NZW4
SDSSNSSDSSDSSDS	DSPP	871	Q9NZW4
SSDSSDSSDSNESSN	DSPP	876	Q9NZW4
DSSDSNESSNSSDSS	DSPP	881	Q9NZW4
NESSNSSDSSDSSNS	DSPP	886	Q9NZW4
SSDSSDSSNSSDSDS	DSPP	891	Q9NZW4
DSSNSSDSDSSDSSN	DSPP	896	Q9NZW4
SDSDSSDSSNSSDSS	DSPP	901	Q9NZW4
SDSSNSSDSSDSSNS	DSPP	906	Q9NZW4
SSDSSDSSNSSDSSE	DSPP	911	Q9NZW4
DSSNSSDSSESSNSS	DSPP	916	Q9NZW4
SDSSESSNSSDNSNS	DSPP	921	Q9NZW4
DNSNSSDSSNSSDSS	DSPP	931	Q9NZW4
SDSSNSSDSSDSSDS	DSPP	936	Q9NZW4
SSDSSDSSDSSNSSD	DSPP	941	Q9NZW4
DSSDSSNSSDSSNSS	DSPP	946	Q9NZW4
SSNSSDSSNSSDSSD	DSPP	956	Q9NZW4
DSSNSSDSSDSNSSD	DSPP	961	Q9NZW4
SDSSDSNSSDSSDSS	DSPP	966	Q9NZW4
SNSSDSSDSSNSSDS	DSPP	971	Q9NZW4
SSDSSNSSDSSDSSD	DSPP	976	Q9NZW4
NSSDSSDSSDSSDSS	DSPP	981	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	986	Q9NZW4
SSDSSDSSDSSNSSD	DSPP	991	Q9NZW4
DSSDSSNSSDSSDSS	DSPP	996	Q9NZW4
SNSSDSSDSSDSSDS	DSPP	1001	Q9NZW4
SSDSSDSSDSSNSSD	DSPP	1006	Q9NZW4
DSSDSSNSSDSSNSS	DSPP	1011	Q9NZW4
SSNSSDSSNSSDSSD	DSPP	1021	Q9NZW4
DSSNSSDSSDSSDSS	DSPP	1026	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	1031	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	1036	Q9NZW4
DSSDSSDSSDSSDSS	DSPP	1041	Q9NZW4
SDSSDSSDSSNSSDS	DSPP	1046	Q9NZW4
SSDSSNSSDSSDSSD	DSPP	1051	Q9NZW4
NSSDSSDSSDSSDSS	DSPP	1056	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	1061	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	1066	Q9NZW4
DSSDSSDSSDSSESS	DSPP	1071	Q9NZW4
SDSSDSSESSDSSDS	DSPP	1076	Q9NZW4
SSESSDSSDSSNSSD	DSPP	1081	Q9NZW4
DSSDSSNSSDSSDSS	DSPP	1086	Q9NZW4
SNSSDSSDSSDSSDS	DSPP	1091	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	1096	Q9NZW4
DSSDSSDSSDSSDSS	DSPP	1101	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	1106	Q9NZW4
SSDSSDSSDSSNSSD	DSPP	1111	Q9NZW4
DSSDSSNSSDSSDSS	DSPP	1116	Q9NZW4
SNSSDSSDSSDSSDS	DSPP	1121	Q9NZW4
SSDSSDSSDSSDSSN	DSPP	1126	Q9NZW4
DSSDSSDSSNSSDSS	DSPP	1131	Q9NZW4
SDSSNSSDSSDSSES	DSPP	1136	Q9NZW4
SSDSSDSSESSDSSD	DSPP	1141	Q9NZW4
DSSESSDSSDSSDSS	DSPP	1146	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	1151	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	1156	Q9NZW4
DSSDSSDSSDSSDSS	DSPP	1161	Q9NZW4
SDSSDSSDSSDSSNS	DSPP	1166	Q9NZW4
SSDSSDSSNSSDSSD	DSPP	1171	Q9NZW4
DSSNSSDSSDSSDSS	DSPP	1176	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	1181	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	1186	Q9NZW4
DSSDSSDSSDSSDSS	DSPP	1191	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	1196	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	1201	Q9NZW4
DSSDSSDSSDSSDSS	DSPP	1206	Q9NZW4
SDSSDSSDSSDSSDS	DSPP	1211	Q9NZW4
SSDSSDSSDSSDSSD	DSPP	1216	Q9NZW4
DSSDSSDSSDSNESS	DSPP	1221	Q9NZW4
SDSSDSNESSDSSDS	DSPP	1226	Q9NZW4
SNESSDSSDSSDSSD	DSPP	1231	Q9NZW4
DSSDSSDSSDSSNSS	DSPP	1236	Q9NZW4
SDSSDSSNSSDSSDS	DSPP	1241	Q9NZW4
SSNSSDSSDSSDSSD	DSPP	1246	Q9NZW4
DSSDSSDSSDSTSDS	DSPP	1251	Q9NZW4
SSSGSDSESESSSSD	AFF4	436	Q9UHB7
SSSDSDSDSDSSGTS	FBXL19	326	Q6PCT2
SSSSSSSSSSDSDSE	JMJD6	346	Q6NYC1
SSSDSSSSSSDSDTD	IMUP	51	Q9GZP8
SSSASSSSESDSSDS	CWC22	671	Q9HCG8
SSSESDSSDSDSDSS	CWC22	676	Q9HCG8
DSSSESSSEESDSSS	CWC22	691	Q9HCG8
EDESSSSSSSSSSED	DCAF5	556	Q96JK2
TSSDDSSSDESSSSE	KANK1	1006	Q14678
SSSSSSSSSSEDSDS	MEIOSIN	456	C9JSJ3
SSSSSSSDSDSSSDS	PPIG	196	Q13427
SSDSDSSSDSQSSSD	PPIG	201	Q13427
SSSDSQSSSDSSDSE	PPIG	206	Q13427
SSSPSSSSSESSEDD	PRICKLE3	546	O43900
SSSSSSSSEESDSDE	CHD9	2186	Q3L8U1
SDSTSSSSEDSDSSN	CHD9	2881	Q3L8U1
SSSTSSSSSSDEEDD	CBX2	111	Q14781
SSSSDSSDSDEDSSS	GPALPP1	41	Q8IXQ4
PSNSSSSSDSSSDSD	MLLT1	376	Q03111
VSSDSDSDSDLSSSS	RPH3AL	206	Q9UNE2
SDSDSNSSSSSSDSD	RTF1	156	Q92541
NSSSSSSDSDSSSED	RTF1	161	Q92541
SSSSSSSGSSSSDDE	SOX4	386	Q06945
EGSDSSSNSSSSSES	NKTR	196	P30414
SSNSSSSSESSSESE	NKTR	201	P30414
EESDSSSSSSSTSDS	NAP1L3	31	Q99457
ENDSTSDSESSSSSS	SETD1A	1026	O15047
SSSSSSSSESSSEDE	SETD1A	1051	O15047
SSSSSSSSDTSDSDS	BRD2	786	P25440
SSSAESESTSDSDSS	AFF1	466	P51825
SESTSDSDSSSDSES	AFF1	471	P51825
DSDSSSDSESESSSS	AFF1	476	P51825
SSDSSDSSSSSSDDS	SPEN	291	Q96T58
SSENDLSSESSSSSS	RNF111	256	Q6ZNA4
SSSSSTHSDSSSDNE	RPAP2	206	Q8IXW5
SSSSSSSSSSESNDE	TMEM40	61	Q8WWA1
SEDSDTDESSSSSSS	ZCCHC10	136	Q8TBK6
TSSSSSDSDSDSSSS	ZCCHC10	156	Q8TBK6
SDSDSDSSSSSSSST	ZCCHC10	161	Q8TBK6
DSETDSDSSSSSSSS	NAF1	121	Q96HR8